share_log

【国盛证券】昌九生化:08年3季报点评

[Guosheng Securities] Changjiu Biochemistry: comments on the third Quarterly report of 2008

國盛證券 ·  Nov 3, 2008 00:00  · Researches

Analysis of the operating situation in the third quarter of 2008 profit rose from the same period last year compared with the same period in 2007, the company's main business income and main business profit increased significantly, and the net profit also increased significantly. However, compared with the second quarter, when the company's revenue increased by about 6.39%, its operating profit and net profit decreased by 54% and 76%, respectively. Acrylamide products are the main growth point of the company's main business income and profits. due to the low gross profit margin of acrylamide at present, although the revenue keeps growing to a certain extent, when the revenue of other products with higher gross profit margin such as urea and methanol begins to decline, it has a certain impact on the overall profitability of the company.

Looking forward to the future of the company, acrylamide company regards acrylamide as the focus of its future development. At present, the company is expanding its acrylamide production capacity. Other main products are urea, methanol, products are coal as raw materials, although the price of coal has declined, but the recent decline in product demand has led to a rapid decline in product prices. The future growth of the company still depends on the production and marketing of acrylamide.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment